Drug Side Effects
Search
ANAL CANCER STAGE 0
ANAL CANCER STAGE 0
was reported 31 times
ANAL CANCER STAGE 0 is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
CCR5 Co-receptor Antagonist [EPC]
1
0.0004
1
Protease Inhibitor [EPC]
8
0.0002
2
Cytochrome P450 3A Inhibitor [EPC]
8
0.0001
3
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
5
0.0001
4
Sulfone [EPC]
1
0.0001
5
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
8
0.0001
6
Androgen [EPC]
1
0.0000
7
Phenothiazine [EPC]
1
0.0000
8
Pyrimidine Synthesis Inhibitor [EPC]
1
0.0000
9
Methylxanthine [EPC]
1
0.0000
10
Central Nervous System Stimulant [EPC]
1
0.0000
11
Thalidomide Analog [EPC]
5
0.0000
12
beta-Adrenergic Blocker [EPC]
2
0.0000
13
Angiotensin 2 Receptor Blocker [EPC]
2
0.0000
14
Benzodiazepine [EPC]
4
0.0000
15
Corticosteroid [EPC]
6
0.0000
16
Atypical Antipsychotic [EPC]
2
0.0000
17
Nonsteroidal Anti-inflammatory Drug [EPC]
5
0.0000
18
Opioid Agonist [EPC]
1
0.0000
19
Proton Pump Inhibitor [EPC]
2
0.0000
20
Vitamin D [EPC]
1
0.0000
21
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
22
Loop Diuretic [EPC]
1
0.0000
23
Platelet Aggregation Inhibitor [EPC]
1
0.0000
24
Tumor Necrosis Factor Blocker [EPC]
1
0.0000